Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans
نویسندگان
چکیده
منابع مشابه
Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.
CYP2D6 differences have already been demonstrated within Latin American populations by the CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics (RIBEF, as per the acronym in Spanish). However, within the population of Costa Rica, no research has been conducted until now, even though this population has a trihybrid component ancestry that represents an interesting condition. Thu...
متن کاملGenetic Polymorphisms of Genes Gstm1 and Cyp2d6 and Bladder Cancer
Objective: To study the relationship between GSTM1 and CYP2D6 polymorphisms and exposure to risk factors, and the occurrence of bladder cancer. Patients and Methods: The study included 77 patients with fully characterized transitional cell carcinoma of the bladder, from whom a complete history was taken, and 191 healthy individuals, who served as controls for the genetic assessment. Using a pol...
متن کاملShort Communication CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
Cyp3A5 activity varies within any given ethnic population, suggesting that genetic variation within the Cyp3A5 gene may be the most important contributor to interindividual and interracial differences in Cyp3A-dependent drug clearance and response. The full extent of Cyp3A5 polymorphism in a white and an indigenous African population was analyzed using DNA direct sequencing procedures. The pres...
متن کاملCYP2D6*4 polymorphisms and breast cancer risk
CYP2D6 gene plays an important role in detoxification of many drugs and plays a crucial role in the metabolism of tamoxifen, used in endocrine therapy. In the present study, the heterozygous frequency IM (40.8%) was significantly increased in breast cancer patients when compared to controls. When the data on IM and PM were pooled, significant increase in the frequency of pooled genotype in dise...
متن کاملAssociation between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment
The aim of the study was to evaluate the association between genetic polymorphisms of CYP2D6 and outcomes in breast cancer patients with tamoxifen treatment. We evaluated the CYP2D6 genetic polymorphisms in 766 breast cancer patients. Among them, 110 patients whose samples were prospectively collected before surgery and treated with tamoxifen were included to evaluate the association between CY...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista de Biología Tropical
سال: 2014
ISSN: 2215-2075,0034-7744
DOI: 10.15517/rbt.v62i4.12916